Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1256-1260

  Xiu, Bing Shui ^a   Ling, Shi Gan ^a   Song, Xiao Guo ^a   Zhang, He Qiu ^a   Chen, Kun ^a   Zhu, Cui Xia ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HEPATITIS C ANTIBODY; HYPERVIABLE REGION 1; HYPERVIABLE REGION 1 ANTIGEN; RECOMBINANT HYPERVIABLE REGION 1 ANTIGEN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; AMINO ACID SYNTHESIS; ANTIGEN ANTIBODY REACTION; ANTIGEN PURIFICATION; ARTICLE; BLOOD ANALYSIS; CHIMERA; CHINA; CLONING; COMPUTER PROGRAM; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIGATION; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN INDUCTION; VACCINE PRODUCTION; VIRUS ISOLATION;

EID: 0038051564     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1256     Document Type: Article

References (46)

1. Alter HJ. To C or not to C. These are the questions. Blood 1995; 85: 1681-1695
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362
3. Sela B. New approaches to immune against hepatitis C virus Harefuah 2002; 141: 1076-1080
4. Esumi M, Rikihisa T, Nishimura S, Goto J, Mizuno K, Zhou YH, Shikata T. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees. Arch Virol 1999; 144: 973-980
5. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994; 91: 7792-7796
6. Cerino A, Meola A, Segagni L, Furione M, Marciano S, Triyatni M, Liang TJ, Nicosia A, Mondelli MU. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles. J Immunol 2001; 167: 3878-3886
7. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996; 93: 15394-15399
8. Zhou YH, Takekoshi M, Maeda F, Ihara S, Esumi M. Recombinant antibody Fab against the hypervariable region 1 of hepatitis C virus blocks the virus adsorption to susceptible cells in vitro. Antiviral Res 2002; 56: 51-59
9. Goto J, Nishimura S, Esumi M, Makizumi K, Rikihisa T, Nishihara T, Mizuno K, Zhou Y, Shikata T, Fujiyama S, Tomita K. Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1. Hepatol Res 2001; 19: 270-283
10. Zibert A, Schreirer E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995; 208: 653-661
11. Korenaga M, Hino K, Katoh Y, Yamaguchi Y, Okuda M, Yoshioka K, Okita K. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J Viral Hepat 2001; 8: 331-340
12. Gao G, Buskell Z, Seeff L, Tabor E. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J Med Virol 2002; 68: 60-67
13. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 1995; 69: 4407-4412
14. Puntoriero G, Meola A, Lahm A, Zucchelli S, Ercole BB, Tafi R, Pezzanera M, Mondelli MU, Cortese R, Tramontano A, Galfré G, Nicosia A. Towards a solution for hepatitis C virus hypervariability: Mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 1998; 17: 3521-3533
15. Watanabe K, Yoshioka K, Ito H, Ishigami M, Takagi K, Utsunomiya S, Kobayashi M, Kishimoto H, Yano M, Kakumu S. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence. Virology 1999; 264: 153-158
16. Mondelli MU, Cerino A, Segagni L, Meola A, Cividini A, Silini E, Nicosia A. Hypervariable region 1 of hepatitis C virus: Immunological decoy or biologically relevant domain? Antiviral Res 2001; 52: 153-159
17. Rispeter K, Lu M, Behrens SE, Fumiko C, Yoshida T, Roggendorf M. Hepatitis C virus variability: Sequence analysis of an isolate after 10 years of chronic infection. Virus Genes 2000; 21: 179-188
18. Fan X, Di Bisceglie AM. Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2. J Med Virol 2001; 64: 325-333
19. Lin HJ, Seeff LB, Barbosa L, Hollinger FB. Occurrence of identifical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: Divergence over time. Hepatology 2001; 34: 424-429
20. Lu L, Nakano T, Orito E, Mizokami M, Robertson BH. Evaluation of accumulation of hepatitis C virus mutations in a chronically infected chimpanzee: Comparison of the core, E1, HVR1, and NS5b regions. J Virol 2001; 75: 3004-3009
21. Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. J Virol 1999; 73: 2938-2946
22. Zucchelli S, Roccasecca R, Meola A, Ercole BB, Tafi R, Dubuisson J, Galfre G, Cortese R, Nicosia A. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization. Hepatology 2001; 33: 692-703
23. Roccasecca R, Folgori A, Ercole BB, Puntoriero G, Lahm A, Zucchelli S, Tafi R, Pezzanera M, Galfre G, Tramontano A, Mondelli MU, Pessi A, Nicosia A, Cortese R, Meola A. Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus. Int Rev Immunol 2001; 20: 289-300
24. Roccasecca R, Folgori A, Ercole BB, Puntoriero G, Lahm A, Zucchelli S, Tafi R, Pezzanera M, Galfre G, Tramontano A, Mondelli MU, Pessi A, Nicosia A, Cortese R, Meola A. Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. Mol Immunol 2001; 38: 485-492
25. Li C, Candotti D, Allain JP. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. J Virol 2001; 75: 12412-12420
26. Shang D, Zhai W, Allain JP. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits. Virology 1999; 258: 396-405
27. Zhou YH, Moriyama M, Esumi M. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus. Virology 1999; 256: 360-370
28. Yagi S, Kashiwakuma T, Yamaguchi K, Chiba Y, Ohtsuka E, Hasegawa A. An epitope chimeric antigen for the hepatitis C virus serologial screening test. Biol Pharm Bull 1996; 19: 1254-1560
29. Paolini R, Marson P, Vicarioto M, Ongaro G, Viero M, Girolami A. Anti-hepatitis C virus serology in patients affected with congenital coagulation defects: A comparative study using three second generation ELISA tests. Transfus Sci 1994; 15: 303-311
30. Bosch FX, Ribes J. Epidemiology of liver cancer in Europe. Can J Gastroenterol 2000; 14: 621-630
31. Simmonds P. Viral heterogeneity of the hepatitis C virus. J Hepatol 1999; 31(Suppl 31): 54-60
32. Cai Q, Zhang X, Tian L, Yuan M, Jin G, Lu Z. Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China. J Med Virol 2002; 67: 490-500
33. Oliveira ML, Bastos FI, Sabino RR, Paetzold U, Schreier E, Pauli G, Yoshida CF. Distribution of HCV genotypes among different exposure categories in Brazil. Braz J Med Biol Res 1999; 32: 279-282
34. Zibert A, Meisel H, Kraas W, Schulz A, Jung G, Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology 1997; 25: 1245-1249
35. Lechner S, Rispeter K, Meisel H, Kraas W, Jung G, Roggendorf M, Zibert A. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology 1998; 243: 313-321
36. Isaguliants MG, Widell A, Zhang SM, Sidorchuk A, Levi M, Smirnov VD, Santantonio T, Diepolder HM, Pape GR, Nordenfelt E. Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides. J Med Virol 2002; 66: 204-217
37. Del Porto P, Puntoriero G, Scotta C, Nicosia A, Piccolella E. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment. Virology 2000; 269: 313-324
38. Hjalmarsson S, Blomberg J, Grillner L, Pipkorn R, Allander T. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection. J Med Virol 2001; 64: 117-124
39. Hattori M, Yoshioka K, Aiyama T, Iwata K, Terazawa Y, Ishigami M, Yano M, Kakumu S. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: Relation to viral loads and response to interferon. Hepatology 1998; 27: 1703-1710
40. Pawlotsky JM, Germanidis G, Frainais PO, Bouvier M, Soulier A, Pellerin M, Dhumeaux D. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 1999; 73: 6490-6499
41. Zhou YH, Sugitani M, Esumi M. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees. Arch Virol 2002; 147: 1955-1962
42. Wang Y, Hao F, Huang Y. Molecular design and immunoreactivity studies of multiple antigen peptide corresponding to hypervariable region 1 sequence of hepatitis C virus. Zhonghua Ganzangbing Zazhi 2000; 8: 48-50
43. Duenas-Carrera S, Vina A, Garay HE, Reyes O, Alvarez-Lajonchere L, Guerra I, Gonzalez LJ, Morales J. Immunological evaluation of Escherichia coli-derived hepatitis C virus second envelope protein (E2) variants. J Pept Res 2001; 58: 221-228
44. Bockmann S, Mohrdieck K, Paegelow I. Influence of interleukin-1 beta on bradykinin-induced responses in guinea pig peritoneal macrophages. Inflamm Res 1999; 48: 56-62
45. Akasu T, Tsurusaki M. Effects of interleukin-1 beta on neurons in mammalian pelvic ganglia. Kurume Med J 1999; 46: 143-150
46. Boraschi D, Tagliabue A. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants. Methods 1999; 19: 108-113